What is HC Wainwright's Estimate for Myomo FY2028 Earnings?

Myomo, Inc. (NYSEAMERICAN:MYO - Free Report) - HC Wainwright issued their FY2028 EPS estimates for Myomo in a research note issued on Wednesday, November 13th. HC Wainwright analyst S. Lee forecasts that the company will post earnings per share of $0.41 for the year. HC Wainwright currently has a "Buy" rating and a $7.50 price target on the stock. The consensus estimate for Myomo's current full-year earnings is ($0.17) per share.

Myomo (NYSEAMERICAN:MYO - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.01. The company had revenue of $9.21 million for the quarter, compared to analyst estimates of $7.95 million. Myomo had a negative return on equity of 86.30% and a negative net margin of 33.22%.

Other research analysts have also recently issued research reports about the stock. Ascendiant Capital Markets boosted their price objective on shares of Myomo from $8.50 to $9.00 and gave the stock a "buy" rating in a research report on Tuesday. Craig Hallum started coverage on Myomo in a research report on Wednesday, July 31st. They set a "buy" rating and a $7.00 target price for the company.

Myomo Trading Up 2.3 %

Myomo stock traded up $0.11 during trading hours on Thursday, hitting $4.83. 291,583 shares of the stock were exchanged, compared to its average volume of 328,421. The stock has a market capitalization of $146.11 million, a price-to-earnings ratio of -20.43 and a beta of 1.56. Myomo has a 12 month low of $2.51 and a 12 month high of $5.64.

Institutional Trading of Myomo

Several hedge funds have recently bought and sold shares of the stock. Herr Investment Group LLC increased its holdings in Myomo by 67.9% during the 1st quarter. Herr Investment Group LLC now owns 1,645,827 shares of the company's stock worth $5,382,000 after purchasing an additional 665,330 shares in the last quarter. Rosalind Advisors Inc. raised its position in Myomo by 8.9% in the 2nd quarter. Rosalind Advisors Inc. now owns 2,664,999 shares of the company's stock valued at $8,555,000 after buying an additional 217,259 shares during the last quarter. Accel Wealth Management lifted its stake in Myomo by 6.0% in the 2nd quarter. Accel Wealth Management now owns 43,882 shares of the company's stock valued at $141,000 after acquiring an additional 2,500 shares in the last quarter. Bailard Inc. acquired a new position in Myomo during the 2nd quarter worth approximately $109,000. Finally, AIGH Capital Management LLC grew its stake in shares of Myomo by 4.1% during the 2nd quarter. AIGH Capital Management LLC now owns 2,917,997 shares of the company's stock worth $9,367,000 after acquiring an additional 115,405 shares in the last quarter. 44.99% of the stock is currently owned by institutional investors and hedge funds.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.